Takeda Pharmaceutical's IFRS net income for fiscal year 2021 was JP¥230.166 billion, down 38.8% from JP¥376.171 billion in the previous year. Revenues rose 11.6% to JP¥3.569 trillion from JP¥3.198 trillion a year earlier.